| Myeloid Leukemia altered in cohorts of …ALTERED_INderived117 of 117show fewer |
|---|
| ← altered in cohorts of | FLT3 278 / 903 cases (31 %) · ssm · aml_ohsu_2022 · largest of 7 cohorts | — | — | Acute Myeloid Leukemia | 7 | Observed | cbioportal | graph → |
| ← altered in cohorts of | NPM1 233 / 903 cases (26 %) · ssm · aml_ohsu_2022 · largest of 7 cohorts | — | — | Acute Myeloid Leukemia | 7 | Observed | cbioportal | graph → |
| ← altered in cohorts of | DNMT3A 197 / 903 cases (22 %) · ssm · aml_ohsu_2022 · largest of 5 cohorts | — | — | Acute Myeloid Leukemia | 5 | Observed | cbioportal | graph → |
| ← altered in cohorts of | VIPR2 29 / 200 cases (14 %) · ssm · TCGA-LAML | — | — | Acute Myeloid Leukemia | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | C8orf33 27 / 200 cases (14 %) · ssm · TCGA-LAML | — | — | Acute Myeloid Leukemia | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | COMMD5 27 / 200 cases (14 %) · ssm · TCGA-LAML | — | — | Acute Myeloid Leukemia | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | DLGAP2 27 / 200 cases (14 %) · ssm · TCGA-LAML | — | — | Acute Myeloid Leukemia | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | MYC 27 / 200 cases (14 %) · ssm · TCGA-LAML | — | — | Acute Myeloid Leukemia | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | RPL8 27 / 200 cases (14 %) · ssm · TCGA-LAML | — | — | Acute Myeloid Leukemia | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | ZNF16 27 / 200 cases (14 %) · ssm · TCGA-LAML | — | — | Acute Myeloid Leukemia | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | ZNF250 27 / 200 cases (14 %) · ssm · TCGA-LAML | — | — | Acute Myeloid Leukemia | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | ZNF517 27 / 200 cases (14 %) · ssm · TCGA-LAML | — | — | Acute Myeloid Leukemia | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | ZNF7 27 / 200 cases (14 %) · ssm · TCGA-LAML | — | — | Acute Myeloid Leukemia | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | NRAS 119 / 903 cases (13 %) · ssm · aml_ohsu_2022 · largest of 5 cohorts | — | — | Acute Myeloid Leukemia | 5 | Observed | cbioportal | graph → |
| ← altered in cohorts of | TET2 118 / 903 cases (13 %) · ssm · aml_ohsu_2022 · largest of 2 cohorts | — | — | Acute Myeloid Leukemia | 2 | Observed | cbioportal | graph → |
| ← altered in cohorts of | COL22A1 26 / 200 cases (13 %) · ssm · TCGA-LAML | — | — | Acute Myeloid Leukemia | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | CYC1 26 / 200 cases (13 %) · ssm · TCGA-LAML | — | — | Acute Myeloid Leukemia | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | DYNC2I1 26 / 200 cases (13 %) · ssm · TCGA-LAML | — | — | Acute Myeloid Leukemia | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | ERICH1 26 / 200 cases (13 %) · ssm · TCGA-LAML | — | — | Acute Myeloid Leukemia | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | FBXO25 26 / 200 cases (13 %) · ssm · TCGA-LAML | — | — | Acute Myeloid Leukemia | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | LY6D 26 / 200 cases (13 %) · ssm · TCGA-LAML | — | — | Acute Myeloid Leukemia | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | LY6K 26 / 200 cases (13 %) · ssm · TCGA-LAML | — | — | Acute Myeloid Leukemia | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | LYNX1 26 / 200 cases (13 %) · ssm · TCGA-LAML | — | — | Acute Myeloid Leukemia | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | LYNX1-SLURP2 26 / 200 cases (13 %) · ssm · TCGA-LAML | — | — | Acute Myeloid Leukemia | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | LYPD2 26 / 200 cases (13 %) · ssm · TCGA-LAML | — | — | Acute Myeloid Leukemia | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | OR4F21 26 / 200 cases (13 %) · ssm · TCGA-LAML | — | — | Acute Myeloid Leukemia | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | PSCA 26 / 200 cases (13 %) · ssm · TCGA-LAML | — | — | Acute Myeloid Leukemia | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | PUF60 26 / 200 cases (13 %) · ssm · TCGA-LAML | — | — | Acute Myeloid Leukemia | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | SLURP1 26 / 200 cases (13 %) · ssm · TCGA-LAML | — | — | Acute Myeloid Leukemia | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | SLURP2 26 / 200 cases (13 %) · ssm · TCGA-LAML | — | — | Acute Myeloid Leukemia | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | TDRP 26 / 200 cases (13 %) · ssm · TCGA-LAML | — | — | Acute Myeloid Leukemia | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | TG 26 / 200 cases (13 %) · ssm · TCGA-LAML | — | — | Acute Myeloid Leukemia | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | THEM6 26 / 200 cases (13 %) · ssm · TCGA-LAML | — | — | Acute Myeloid Leukemia | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | TRPV5 26 / 200 cases (13 %) · ssm · TCGA-LAML | — | — | Acute Myeloid Leukemia | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | ZNF34 26 / 200 cases (13 %) · ssm · TCGA-LAML | — | — | Acute Myeloid Leukemia | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | ZNF596 26 / 200 cases (13 %) · ssm · TCGA-LAML | — | — | Acute Myeloid Leukemia | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | ZNF783 26 / 200 cases (13 %) · ssm · TCGA-LAML | — | — | Acute Myeloid Leukemia | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | ABCF2 25 / 200 cases (13 %) · ssm · TCGA-LAML | — | — | Acute Myeloid Leukemia | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | ADCY8 25 / 200 cases (13 %) · ssm · TCGA-LAML | — | — | Acute Myeloid Leukemia | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | ADGRB1 25 / 200 cases (13 %) · ssm · TCGA-LAML | — | — | Acute Myeloid Leukemia | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | AGO2 25 / 200 cases (13 %) · ssm · TCGA-LAML | — | — | Acute Myeloid Leukemia | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | ARC 25 / 200 cases (13 %) · ssm · TCGA-LAML | — | — | Acute Myeloid Leukemia | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | ARHGAP39 25 / 200 cases (13 %) · ssm · TCGA-LAML | — | — | Acute Myeloid Leukemia | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | ARMC1 25 / 200 cases (13 %) · ssm · TCGA-LAML | — | — | Acute Myeloid Leukemia | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | ASAP1 25 / 200 cases (13 %) · ssm · TCGA-LAML | — | — | Acute Myeloid Leukemia | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | BOP1 25 / 200 cases (13 %) · ssm · TCGA-LAML | — | — | Acute Myeloid Leukemia | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | CCN4 25 / 200 cases (13 %) · ssm · TCGA-LAML | — | — | Acute Myeloid Leukemia | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | CSMD3 25 / 200 cases (13 %) · ssm · TCGA-LAML | — | — | Acute Myeloid Leukemia | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | CYP11B1 25 / 200 cases (13 %) · ssm · TCGA-LAML | — | — | Acute Myeloid Leukemia | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | CYP11B2 25 / 200 cases (13 %) · ssm · TCGA-LAML | — | — | Acute Myeloid Leukemia | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | EEF1D 25 / 200 cases (13 %) · ssm · TCGA-LAML | — | — | Acute Myeloid Leukemia | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | EFR3A 25 / 200 cases (13 %) · ssm · TCGA-LAML | — | — | Acute Myeloid Leukemia | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | EPPK1 25 / 200 cases (13 %) · ssm · TCGA-LAML | — | — | Acute Myeloid Leukemia | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | ESYT2 25 / 200 cases (13 %) · ssm · TCGA-LAML | — | — | Acute Myeloid Leukemia | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | EXOSC4 25 / 200 cases (13 %) · ssm · TCGA-LAML | — | — | Acute Myeloid Leukemia | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | GALNTL5 25 / 200 cases (13 %) · ssm · TCGA-LAML | — | — | Acute Myeloid Leukemia | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | GBX1 25 / 200 cases (13 %) · ssm · TCGA-LAML | — | — | Acute Myeloid Leukemia | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | GIMAP8 25 / 200 cases (13 %) · ssm · TCGA-LAML | — | — | Acute Myeloid Leukemia | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | GLI4 25 / 200 cases (13 %) · ssm · TCGA-LAML | — | — | Acute Myeloid Leukemia | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | GML 25 / 200 cases (13 %) · ssm · TCGA-LAML | — | — | Acute Myeloid Leukemia | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | GPAA1 25 / 200 cases (13 %) · ssm · TCGA-LAML | — | — | Acute Myeloid Leukemia | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | GPR20 25 / 200 cases (13 %) · ssm · TCGA-LAML | — | — | Acute Myeloid Leukemia | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | GRINA 25 / 200 cases (13 %) · ssm · TCGA-LAML | — | — | Acute Myeloid Leukemia | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | GSDMC 25 / 200 cases (13 %) · ssm · TCGA-LAML | — | — | Acute Myeloid Leukemia | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | HHLA1 25 / 200 cases (13 %) · ssm · TCGA-LAML | — | — | Acute Myeloid Leukemia | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | HSF1 25 / 200 cases (13 %) · ssm · TCGA-LAML | — | — | Acute Myeloid Leukemia | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | HTR5A 25 / 200 cases (13 %) · ssm · TCGA-LAML | — | — | Acute Myeloid Leukemia | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | JRK 25 / 200 cases (13 %) · ssm · TCGA-LAML | — | — | Acute Myeloid Leukemia | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | KCNH2 25 / 200 cases (13 %) · ssm · TCGA-LAML | — | — | Acute Myeloid Leukemia | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | KCNK9 25 / 200 cases (13 %) · ssm · TCGA-LAML | — | — | Acute Myeloid Leukemia | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | KCNQ3 25 / 200 cases (13 %) · ssm · TCGA-LAML | — | — | Acute Myeloid Leukemia | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | KHDRBS3 25 / 200 cases (13 %) · ssm · TCGA-LAML | — | — | Acute Myeloid Leukemia | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | LRRC14 25 / 200 cases (13 %) · ssm · TCGA-LAML | — | — | Acute Myeloid Leukemia | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | LY6E 25 / 200 cases (13 %) · ssm · TCGA-LAML | — | — | Acute Myeloid Leukemia | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | LY6H 25 / 200 cases (13 %) · ssm · TCGA-LAML | — | — | Acute Myeloid Leukemia | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | MAF1 25 / 200 cases (13 %) · ssm · TCGA-LAML | — | — | Acute Myeloid Leukemia | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | MFSD3 25 / 200 cases (13 %) · ssm · TCGA-LAML | — | — | Acute Myeloid Leukemia | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | MROH1 25 / 200 cases (13 %) · ssm · TCGA-LAML | — | — | Acute Myeloid Leukemia | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | MROH6 25 / 200 cases (13 %) · ssm · TCGA-LAML | — | — | Acute Myeloid Leukemia | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | NAPRT 25 / 200 cases (13 %) · ssm · TCGA-LAML | — | — | Acute Myeloid Leukemia | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | NDRG1 25 / 200 cases (13 %) · ssm · TCGA-LAML | — | — | Acute Myeloid Leukemia | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | NRBP2 25 / 200 cases (13 %) · ssm · TCGA-LAML | — | — | Acute Myeloid Leukemia | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | NSMCE2 25 / 200 cases (13 %) · ssm · TCGA-LAML | — | — | Acute Myeloid Leukemia | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | OPRK1 25 / 200 cases (13 %) · ssm · TCGA-LAML | — | — | Acute Myeloid Leukemia | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | PHF20L1 25 / 200 cases (13 %) · ssm · TCGA-LAML | — | — | Acute Myeloid Leukemia | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | POU5F1B 25 / 200 cases (13 %) · ssm · TCGA-LAML | — | — | Acute Myeloid Leukemia | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | PPP1R16A 25 / 200 cases (13 %) · ssm · TCGA-LAML | — | — | Acute Myeloid Leukemia | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | PTP4A3 25 / 200 cases (13 %) · ssm · TCGA-LAML | — | — | Acute Myeloid Leukemia | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | PYCR3 25 / 200 cases (13 %) · ssm · TCGA-LAML | — | — | Acute Myeloid Leukemia | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | REPIN1 25 / 200 cases (13 %) · ssm · TCGA-LAML | — | — | Acute Myeloid Leukemia | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | RHPN1 25 / 200 cases (13 %) · ssm · TCGA-LAML | — | — | Acute Myeloid Leukemia | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | SCRIB 25 / 200 cases (13 %) · ssm · TCGA-LAML | — | — | Acute Myeloid Leukemia | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | SHARPIN 25 / 200 cases (13 %) · ssm · TCGA-LAML | — | — | Acute Myeloid Leukemia | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | SLC45A4 25 / 200 cases (13 %) · ssm · TCGA-LAML | — | — | Acute Myeloid Leukemia | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | TRAPPC9 25 / 200 cases (13 %) · ssm · TCGA-LAML | — | — | Acute Myeloid Leukemia | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | TRIB1 25 / 200 cases (13 %) · ssm · TCGA-LAML | — | — | Acute Myeloid Leukemia | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | XKR4 25 / 200 cases (13 %) · ssm · TCGA-LAML | — | — | Acute Myeloid Leukemia | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | ZBED6CL 25 / 200 cases (13 %) · ssm · TCGA-LAML | — | — | Acute Myeloid Leukemia | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | ZFAT 25 / 200 cases (13 %) · ssm · TCGA-LAML | — | — | Acute Myeloid Leukemia | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | ZFHX4 25 / 200 cases (13 %) · ssm · TCGA-LAML | — | — | Acute Myeloid Leukemia | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | ZNF251 25 / 200 cases (13 %) · ssm · TCGA-LAML | — | — | Acute Myeloid Leukemia | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | ZNF623 25 / 200 cases (13 %) · ssm · TCGA-LAML | — | — | Acute Myeloid Leukemia | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | ZNF746 25 / 200 cases (13 %) · ssm · TCGA-LAML | — | — | Acute Myeloid Leukemia | 1 | Observed | gdc | graph → |
| ← altered in cohorts of | IDH2 111 / 903 cases (12 %) · ssm · aml_ohsu_2022 · largest of 5 cohorts | — | — | Acute Myeloid Leukemia | 5 | Observed | cbioportal | graph → |
| ← altered in cohorts of | SRSF2 109 / 903 cases (12 %) · ssm · aml_ohsu_2022 · largest of 2 cohorts | — | — | Acute Myeloid Leukemia | 2 | Observed | cbioportal | graph → |
| ← altered in cohorts of | RUNX1 108 / 903 cases (12 %) · ssm · aml_ohsu_2022 · largest of 2 cohorts | — | — | Acute Myeloid Leukemia | 2 | Observed | cbioportal | graph → |
| ← altered in cohorts of | ASXL1 93 / 903 cases (10 %) · ssm · aml_ohsu_2022 · largest of 2 cohorts | — | — | Acute Myeloid Leukemia | 2 | Observed | cbioportal | graph → |
| ← altered in cohorts of | KIT 88 / 887 cases (9.9 %) · ssm · aml_stjude_2024 · largest of 2 cohorts | — | — | Acute Myeloid Leukemia | 2 | Observed | cbioportal | graph → |
| ← altered in cohorts of | TP53 82 / 903 cases (9.1 %) · ssm · aml_ohsu_2022 · largest of 2 cohorts | — | — | Acute Myeloid Leukemia | 2 | Observed | cbioportal | graph → |
| ← altered in cohorts of | KRAS 78 / 887 cases (8.8 %) · ssm · aml_stjude_2024 · largest of 2 cohorts | — | — | Acute Myeloid Leukemia | 2 | Observed | cbioportal | graph → |
| ← altered in cohorts of | WT1 72 / 903 cases (8.0 %) · ssm · aml_ohsu_2022 · largest of 4 cohorts | — | — | Acute Myeloid Leukemia | 4 | Observed | cbioportal | graph → |
| ← altered in cohorts of | IDH1 71 / 903 cases (7.9 %) · ssm · aml_ohsu_2022 · largest of 2 cohorts | — | — | Acute Myeloid Leukemia | 2 | Observed | cbioportal | graph → |
| ← altered in cohorts of | PTPN11 59 / 887 cases (6.7 %) · ssm · aml_stjude_2024 · largest of 2 cohorts | — | — | Acute Myeloid Leukemia | 2 | Observed | cbioportal | graph → |
| ← altered in cohorts of | STAG2 60 / 903 cases (6.6 %) · ssm · aml_ohsu_2022 · largest of 2 cohorts | — | — | Acute Myeloid Leukemia | 2 | Observed | cbioportal | graph → |
| ← altered in cohorts of | CEBPA 56 / 887 cases (6.3 %) · ssm · aml_stjude_2024 · largest of 3 cohorts | — | — | Acute Myeloid Leukemia | 3 | Observed | cbioportal | graph → |
| ← altered in cohorts of | SF3B1 49 / 903 cases (5.4 %) · ssm · aml_ohsu_2022 · largest of 2 cohorts | — | — | Acute Myeloid Leukemia | 2 | Observed | cbioportal | graph → |
| ← altered in cohorts of | BCOR 48 / 903 cases (5.3 %) · ssm · aml_ohsu_2022 · largest of 2 cohorts | — | — | Acute Myeloid Leukemia | 2 | Observed | cbioportal | graph → |